💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueLearn More

SkinBioTherapeutics PLC (SBTX)

London
Currency in GBP
Disclaimer
11.88
-0.01(-0.08%)
Closed
SBTX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
11.8812.00
52 wk Range
7.0029.50
Bid/Ask
11.50 / 12.50
Prev. Close
11.88
Open
11.88
Day's Range
11.88-12
52 wk Range
7-29.5
Volume
497,854
Average Volume (3m)
990,600
1-Year Change
-43.43%
Fair Value
Unlock
Fair Value Upside
Unlock
SBTX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

SkinBioTherapeutics Company Profile

SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. The company has an agreement with Croda Plc; and operates two research programmes with the University of Manchester, an oral programme and an inflammation study. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.

Compare SBTX to Peers and Sector

Metrics to compare
SBTX
Peers
Sector
Relationship
P/E Ratio
−9.3x−3.0x−0.6x
PEG Ratio
−0.67−0.040.00
Price/Book
7.4x1.3x2.6x
Price / LTM Sales
166.2x22.8x3.1x
Upside (Analyst Target)
304.0%43.3%56.2%
Fair Value Upside
Unlock28.9%7.7%Unlock

FAQ

What Is the SkinBioTherapeutics (SBTX) Stock Price Today?

The SkinBioTherapeutics stock price today is 11.88

What Stock Exchange Does SkinBioTherapeutics Trade On?

SkinBioTherapeutics is listed and trades on the London stock exchange.

What Is the Stock Symbol for SkinBioTherapeutics?

The stock symbol for SkinBioTherapeutics is "SBTX."

What Is the SkinBioTherapeutics Market Cap?

As of today, SkinBioTherapeutics market cap is 26.85M.

What is SkinBioTherapeutics Earnings Per Share?

The SkinBioTherapeutics EPS is -0.017.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.